Summary
Elevance Health, Inc. (then Anthem, Inc.) filed an 8-K on September 13, 2016, primarily to reaffirm its financial guidance for the full year 2016. The company stated that it expected net income to be greater than $9.34 per share, which included over $1.46 per share in net unfavorable items. Excluding these items, the adjusted net income was projected to exceed $10.80 per share. This guidance was consistent with figures reported in their second-quarter earnings release and did not account for any further adjustments beyond those already identified.
Key Highlights
- 1Reaffirmed full-year 2016 net income guidance above $9.34 per share.
- 2Projected net unfavorable items for full-year 2016 to be greater than $1.46 per share.
- 3Expected adjusted net income for full-year 2016 to be greater than $10.80 per share.
- 4Guidance is based on information available as of the second quarter of 2016 earnings release.
- 5No new adjustments beyond those previously reported are included in the guidance.
- 6The report includes standard forward-looking statement disclaimers regarding potential risks and uncertainties.